Made with ❤️ by True Sparrow

Bringing you the latest funding data

PulmoBioMed

Last funding round

Raised
$1,800,000
Round
Unknown
Investors
Led by Northumbria University,North East Venture Fund

Funding News (4)

Feb 8 2024Business Live

Startup details

PulmoBioMed

PulmoBioMed

PulmoBioMed is a biomedical university spin-out based in Newcastle, UK, that has developed a breath test technology to support the diagnosis of asthma and other respiratory conditions, including pneumonias. The company aims to provide quick and non-invasive deep lung sampling for accurate diagnosis and treatment selection.
www.pulmobiomed.com
Newcastle, United Kingdom
Established in 2020
2-10 People
Healthcare, Diagnostics

Founders

Dr Sterghios Moschos

Dr Sterghios Moschos

Chief Executive Officer, Director, and Founder

Newcastle Upon Tyne, England, United Kingdom

Investment details

Raised
$1,800,000
Round
Unknown
Investors
Northumbria University
LEAD
North East Venture Fund
LEAD
SFC Capital

Funding News (3)

Feb 8 2024FinSMEs
Feb 8 2024UKTN
Feb 8 2024Bdaily Business News

Founder Stories

Dr. Sterghois Moschos, PulmoBioMed

Recent 5 from United Kingdom

May2024
1

Today

Swiipr raised a $7.5M Series A from Octopus Ventures and 2 others
London-based Swiipr is a travel paytech company specializing in airline compensation payment systems.
Swiipr

Founders

Tara Spielhagen,

Ian Clowes

In News

FinSMEs
Travel And Tour World
Fintech Finance
2

1 day ago

Spectrum.Life raised $18.3M from ACT Venture Capital and 1 other
London-based Spectrum.Life delivers digital health and wellbeing solutions to organizations and individuals.
Spectrum.Life

Founders

Stuart McGoldrick,

Stephen Costello

In News

FinSMEs
Silicon Canals
Tech.eu
3

4 days ago

Bicycle raised $555M from Forbion and 6 others
UK-based Bicycle Therapeutics develops precision-guided therapeutics using 'bicycle' molecules for cancer and disease treatment.
Bicycle

Founders

Sir Gregory Winter

In News

Tech.eu
4

5 days ago

Viable raised a $3M Seed led by Martin Brailsford
London-based Viable is an Intelligent Finance platform for online and multi-channel sellers.
Viable

Founders

Henry Young,

Franklyn Martin,

Steven Haynes

In News

Silicon Canals
Tech Funding News
5

5 days ago

GreyWolf Therapeutics raised a $49.6M Series B led by ICG’s Life Sciences team
Oxfordshire-based Grey Wolf Therapeutics develops antigen modulation therapies for oncology and autoimmunity.
GreyWolf Therapeutics

Founders

Peter Joyce

In News

EU-Startups
Spot a snag? Report it.
raised@truesparrow.com
Made with ❤️ by True Sparrow
© 2024 True Sparrow Systems Pvt. Ltd. All rights reserved.